Essential Tremor: Clinical Trials

5 trials for Essential Tremor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 5

Follow Essential Tremor: new trials by email Literature Review of Essential Tremor trials Research Report on Essential Tremor

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Propranolol and Botulinum Toxin for Essential Vocal Tremor
Propranolol, Botulinum Toxin - Essential Vocal Tremor, Essential Voice Tremor
Phase 4CompletedEmory University182014-05-012016-04-27
Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response
Ethanol, Propranolol - Essential Tremor, Tremor
Phase 4CompletedUniversity of California, San Diego562013-12-012020-12-02
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Activa RC - Parkinson's Disease, Essential Tremor
Phase 4CompletedMedtronicNeuro1002009-07-012015-03-06
Pregabalin (Lyrica) for the Treatment of Essential Tremor
Pregabalin, Placebo - Essential Tremor
Phase 4CompletedUniversity of South Florida292007-12-012012-06-18
A Pilot Clinical Trial Of Memantine for Essential Tremor
Memantine - Essential Tremor
Phase 4CompletedVA Greater Los Angeles Healthcare System162007-02-012012-06-22

Narrower conditions

Tremor (2)  ·  Dystonia (1)  ·  Parkinson Disease (1)

Broader conditions

Central Nervous System Diseases (5)  ·  Movement Disorders (5)  ·  Nervous System Diseases (5)  ·  Dyskinesias (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Parkinsonian Disorders (1)  ·  Synucleinopathies (1)

Interventions

Propranolol (2)  ·  Botulinum Toxins (1)  ·  Ethanol (1)  ·  Memantine (1)  ·  Pregabalin (1)

Sponsors

Emory University (1)  ·  MedtronicNeuro (1)  ·  University of California, San Diego (1)  ·  University of South Florida (1)  ·  VA Greater Los Angeles Healthcare System (1)

Countries

United States (5)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Adrian Handforth, M.D. (1)  ·  Fatta B Nahab, MD (1)  ·  Michael Johns, MD (1)  ·  Theresa A Zesiewicz, MD (1)

NIH funding

R01NS073683 (1)